Replies to post #2334 on Gilead Sciences Inc (GILD)

[DewDiligence]

No, because Epclusa is intended mainly for genotype-3 patients.

Sovaldi is a component of Harvoni, which is a better option than Epclusa for GT1 patients.

Standalone Sovaldi, on the other hand, is now effectively obsolete.